Our Team – Secretariat & Board
Our team in Brussels provides expert insights into legal, public policy, and government affairs. Together with our members, the EUCOPE Secretariat analyses, monitors, and engages on multiple topics and issues in the world of pharmaceuticals, biotechnologies and medical technologies. Meet our Board Members and Secretariat.
EUCOPE Board Members
- Jan G. Smith – Chairman (Circius Pharma)
- Leslie Galloway – Vice Chairman (EMIG – Ethical Medicines Industry Group)
- Diego Ardigò (Chiesi)
- Toon Digneffe (Takeda)
- Benjamin Gannon (Guardant Health)
- Rüdiger Gatermann (CSL Behring)
- Gunther Herr (Heel)
- Christian Hill (MAP Patient Access)
- Kai Joachimsen (BPI)
- Peter Martin (Norgine)
- Konstantinos Panagoulias (VIANEX S.A.)
Dr. Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). From 2008 to 2013, he was also Head of the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he worked as a lawyer at Sträter Law Firm in Germany with a special focus on managed entry agreements and licensing of pharmaceuticals. Alexander has also worked in the field of competition law with the European Commission and in the pharmaceutical industry. As a research assistant at Duke University (USA), he has dealt with international pharmaceutical law. His doctorate was supervised by the former judge at the European Court of Justice, Prof. Dr. Ulrich Everling.
Deputy Secretary-General and Legal Counsel
Dr Oliver Sude is the Deputy Secretary General and General Counsel of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). He provides strategic legal advice on all legislative and policy dossiers relevant to the EUCOPE membership.
Oliver is a German-qualified lawyer with more than 20 years’ experience in the field of life sciences. Before joining EUCOPE, he worked with international law firms focusing on EU regulatory affairs, intellectual property, and market access issues.
Dr Axel Korth
Senior Legal & Regulatory Affairs Advisor
Dr. Axel Korth is the Senior Legal and Regulatory Affairs Advisor to the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). He represents EUCOPE at EC, EMA, HMA, CMDh, and other fora and focuses on regulatory affairs and the provision of strategic advice on legislative proposals and policy dossiers. He also coordinates EUCOPE’s Regulatory Affairs working group and several of its focus groups including, amongst others, Research & Development, Clinical Trials, Medical Devices, and Pharmacovigilance.
Axel is a senior life sciences lawyer with over 15 years’ experience both as an in-house legal counsel as well as in private practice. Prior to joining EUCOPE, Axel worked as Head Legal DACH at Biogen with a focus on market access, pricing and reimbursement, general healthcare law and compliance, antitrust and competition, public policy and government affairs. Prior thereto, Axel worked in commercial legal roles as Head Legal MEA and Senior Legal Counsel WEMEA at Sandoz (Novartis group) and held positions of continuing seniority at international law firms Shearman & Sterling LLP and Taylor Wessing.
Government Affairs Director
Vittoria Carraro is the Director for Government Affairs for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). She leads EUCOPE’s work on pharmaceutical incentives and rare diseases. Previously, she was External Relations Director for the European Pain Federation, a European non-profit healthcare professionals organisation focused on pain management, and Account Manager (Health Policy and Market Access) for Edelman, a global public affairs consultancy. Ms Carraro has been working on innovation and health policies through her accumulated professional experience including with the European Commission (DG Sante), national and regional governmental institutions. She was a Member of the Committee on Data for Healthy Societies of the European Health Parliament from 2018-2019 and currently, she is part of the multistakeholder group the European Expert Group on Orphan Drugs Incentives.
Public Affairs & Policy Manager
Matias Olsen is the Public Affairs and Policy Manager for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Matias supports EUCOPE on key topics, covering among others, EU HTA, advanced diagnostics, the Pharmaceutical Strategy, EU’s cancer plan, blood, tissues and cells legislation and relevant market access topics. He coordinates members’ thematic working groups, including the P&R/Market Access Working Group, the Genomics Working Group and the EU HTA Regulation Task Force.
Matias has previously advocated on behalf of European cancer patients, and before moving to Brussels worked in the claims department of the Norwegian Social Security Administration before he switched his role from reimbursements to the control department, where he worked with the coordination of social security within the EU/EEA.
Saskia Jansen-Kilian is the Office Manager for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). As Office Manager, she covers a wide diversity of member relations tasks as well as office management activities. She is responsible for managing finances, providing administrative support to the team, and assisting EUCOPE´s Secretary General.
Prior to joining EUCOPE, Saskia worked for the Permanent Representation of Germany to the European Union. As part of the office management team of the economic department, Saskia accompanied the German Council Presidency and gained insight into the procedures of the European institutions.
Government Affairs Manager
Victor Maertens is the Government Affairs Manager for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Victor leads EUCOPE’s policy work on the Pharmaceutical Strategy and in the area of Cell and Gene Therapy. Prior to joining EUCOPE, Victor worked for Brussels-based consultancies, providing pharmaceutical companies, trade associations, and NGOs advocacy, strategy, and communications advice. His experience and interests include ATMPs, antimicrobial resistance, OMP, blood policy, and neglected tropical diseases.
Dante Di Iulio
Communications & Business Development Manager
Dante Di Iulio is the Communications and Business Development Manager for the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). He is responsible for the overall communications activities of EUCOPE, ensuring visibility, reputation growth and expansion of the organisation. Prior to joining EUCOPE, he served as the Communications Manager for the European Patients’ Forum and has managed several projects, brands and communications campaigns for private and public sector organisations in North America, Africa and Asia.
Leander Vranken is the Policy Officer of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). He will be focusing on Digital Health and other related policy areas. Before joining EUCOPE, Leander worked as a policy researcher at a Brussels based EU affairs consultancy in the EU public health sector where he was extensively involved in the policy monitoring of health-related legislative developments. Furthermore, Leander worked in Dutch national public affairs and EU regional policy for several NGOs based in the Hague and Brussels.